# CYBB

## Overview
The CYBB gene encodes the cytochrome b-245 beta chain, also known as gp91^phox, which is a critical component of the NADPH oxidase complex in phagocytes. This transmembrane protein plays a pivotal role in the immune system by facilitating the production of reactive oxygen species (ROS), which are essential for the destruction of invading pathogens. The cytochrome b-245 beta chain forms a heterodimer with p22^phox, creating a functional unit necessary for the electron transport activity of the oxidase complex. This activity is crucial for the respiratory burst, a rapid release of ROS that aids in microbial killing and immune defense. Mutations in the CYBB gene can lead to X-linked chronic granulomatous disease (X-CGD), a condition marked by recurrent infections due to impaired ROS production (Frazão2015Regulation; Quinn2004Structure). The gene's expression is tightly regulated by various transcription factors and is responsive to inflammatory stimuli, ensuring its activity is modulated during immune responses (Mazzi2004IFNγ; Kautz2001SHP1).

## Structure
The CYBB gene encodes the gp91 phox protein, a critical component of the phagocyte NADPH oxidase complex, also known as flavocytochrome b. This protein is integral to the generation of reactive oxygen species in neutrophils, playing a vital role in host immunity (Quinn2004Structure). The gp91 phox protein forms a heterodimer with p22 phox, and this complex is essential for the electron transport function of the oxidase, transferring electrons from NADPH to oxygen to produce superoxide anions (Quinn2004Structure).

Structurally, gp91 phox contains multiple transmembrane regions, with hydropathy analyses suggesting four to six such regions. It also includes binding domains for flavin adenine dinucleotide (FAD) and NADPH, which are crucial for its redox activity (Quinn2004Structure). The protein coordinates two heme groups, with specific histidine residues (101, 115, 209, and 222) being essential for heme binding. Mutations in these residues are associated with X-linked chronic granulomatous disease (CGD) (Quinn2004Structure).

The gp91 phox protein is glycosylated, a post-translational modification that may influence its function and stability (Quinn2004Structure). Despite the detailed functional insights, specific information on the primary, secondary, tertiary, or quaternary structures of the CYBB protein is not provided in the available context.

## Function
The CYBB gene encodes the gp91-phox component of the NADPH oxidase complex, which is crucial for the production of reactive oxygen species (ROS) in phagocytes such as neutrophils, macrophages, and dendritic cells (Lam2010The; Frazão2015Regulation). This complex plays a vital role in the respiratory burst, a rapid release of ROS that is essential for microbial killing and immune defense (Lam2010The). The primary product of the NADPH oxidase activity is superoxide, which can be converted into other reactive compounds like hydrogen peroxide and hypochlorous acid, contributing to the destruction of pathogens by damaging their DNA, lipids, and proteins (Lam2010The).

In addition to its antimicrobial functions, ROS generated by the NADPH oxidase complex are involved in various immune processes, including chemotaxis, immune modulation, and antigen cross-presentation (Lam2010The). In dendritic cells, NOX2-derived ROS regulate phagosomal pH, affecting antigen degradation and presentation, which is crucial for adaptive immunity (Lam2010The). The CYBB gene's expression is tightly regulated by transcription factors and is responsive to inflammatory stimuli, ensuring its activity is appropriately modulated during immune responses (Frazão2015Regulation).

## Clinical Significance
Mutations in the CYBB gene, which encodes the gp91-phox protein, are primarily associated with X-linked chronic granulomatous disease (X-CGD). This condition is characterized by a deficiency in the NADPH oxidase complex, leading to impaired production of reactive oxygen species in phagocytes. As a result, individuals with X-CGD experience recurrent and severe bacterial and fungal infections due to the inability of their immune cells to effectively kill pathogens (von2006Characterization; Heydari2020Identification).

The mutations in CYBB are diverse, including nonsense, missense, splice-site mutations, and deletions or insertions, which can affect both coding and non-coding regions of the gene. These mutations often result in a complete lack of gp91-phox expression, leading to abolished NADPH oxidase activity (Di2009Molecular; Martel2012Clinical). Some mutations, such as those affecting splice sites, can lead to late-onset CGD, indicating variability in disease presentation (von2006Characterization).

In rare cases, CYBB mutations have been linked to other conditions, such as Mendelian susceptibility to mycobacterial disease (MSMD), where specific mutations in the gene predispose individuals to infections by mycobacterial species (Bustamante2011Germline). Additionally, large deletions in CYBB can be associated with McLeod syndrome, characterized by neurological and hematological abnormalities (Di2009Molecular).

## Interactions
The CYBB gene encodes the gp91^phox protein, a critical component of the NADPH oxidase complex, which is essential for the production of reactive oxygen species in phagocytes. This complex involves several protein interactions. Gp91^phox forms a membrane-bound cytochrome b558 with p22^phox, which is necessary for the activation of NADPH oxidase. The activation process requires the association of cytosolic proteins p67^phox, p47^phox, and p40^phox, as well as Rac GTP-binding proteins, with the cytochrome b558 complex (Mazzi2004IFNγ).

The transcription of the CYBB gene is regulated by various transcription factors. PU.1, a key regulator, binds to the gp91^phox promoter, and its activity is modulated by phosphorylation through protein kinase C (PKC) α and βI. This phosphorylation enhances PU.1's binding to the promoter, facilitating gp91^phox expression (Mazzi2004IFNγ). Additionally, the HAF1 complex, which includes PU.1, IRF1, ICSBP, and CBP, binds to the CYBB promoter to activate transcription. SHP1 protein tyrosine phosphatase can inhibit this interaction, thereby modulating CYBB expression (Kautz2001SHP1). These interactions highlight the complex regulatory mechanisms controlling CYBB gene expression and its role in immune function.


## References


[1. (Lam2010The) Grace Y. Lam, Ju Huang, and John H. Brumell. The many roles of nox2 nadph oxidase-derived ros in immunity. Seminars in Immunopathology, 32(4):415–430, August 2010. URL: http://dx.doi.org/10.1007/s00281-010-0221-0, doi:10.1007/s00281-010-0221-0. This article has 190 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00281-010-0221-0)

[2. (Mazzi2004IFNγ) Paola Mazzi, Marta Donini, Daniela Margotto, Frans Wientjes, and Stefano Dusi. Ifn-γ induces gp91phox expression in human monocytes via protein kinase c-dependent phosphorylation of pu.1. The Journal of Immunology, 172(8):4941–4947, April 2004. URL: http://dx.doi.org/10.4049/jimmunol.172.8.4941, doi:10.4049/jimmunol.172.8.4941. This article has 25 citations.](https://doi.org/10.4049/jimmunol.172.8.4941)

[3. (Frazão2015Regulation) Josias B. Frazão, Alison Thain, Zhiqing Zhu, Marcos Luengo, Antonio Condino‐Neto, and Peter E. Newburger. Regulation of cybb gene expression in human phagocytes by a distant upstream nf‐κb binding site. Journal of Cellular Biochemistry, 116(9):2008–2017, July 2015. URL: http://dx.doi.org/10.1002/jcb.25155, doi:10.1002/jcb.25155. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.25155)

[4. (von2006Characterization) Heiko von Goessel, Johann Peter Hossle, Reinhard Seger, and Tayfun Gungor. Characterization of 17 new cases of x-linked chronic granulomatous disease with seven novel mutations in the cybb gene. Experimental Hematology, 34(4):528–535, April 2006. URL: http://dx.doi.org/10.1016/j.exphem.2006.01.005, doi:10.1016/j.exphem.2006.01.005. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exphem.2006.01.005)

[5. (Martel2012Clinical) Cécile Martel, Michelle Mollin, Sylvain Beaumel, Jean Paul Brion, Charles Coutton, Véronique Satre, Gaëlle Vieville, Mary Callanan, Christine Lefebvre, Alexandra Salmon, Anne Pagnier, Dominique Plantaz, Cécile Bost-Bru, Laurence Eitenschenck, Isabelle Durieu, Daniel Floret, Claire Galambrun, Hervé Chambost, Gérard Michel, Jean-Louis Stephan, Olivier Hermine, Stéphane Blanche, Nathalie Blot, Hervé Rubié, Guillaume Pouessel, Stephanie Drillon-Haus, Bernard Conrad, Klara M. Posfay-Barbe, Zuzana Havlicekova, Tamara Voskresenky-Baricic, Kelecic Jadranka, Maria Cristina Arriazu, Luis Alberto Garcia, Lamia Sfaihi Ben Mansour, Pierre Bordigoni, and Marie José Stasia. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease – identification of eight novel mutations in cybb and ncf2 genes. Journal of Clinical Immunology, 32(5):942–958, May 2012. URL: http://dx.doi.org/10.1007/s10875-012-9698-8, doi:10.1007/s10875-012-9698-8. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-012-9698-8)

[6. (Heydari2020Identification) Atefeh Heydari, Farhad Abolnezhadian, Mahnaz Sadeghi‐Shabestari, Alihossein Saberi, Ahmad Shamsizadeh, Ata A. Ghadiri, and Pegah Ghandil. Identification of cytochrome b‐245, beta‐chain gene mutations, and clinical presentations in iranian patients with x‐linked chronic granulomatous disease. Journal of Clinical Laboratory Analysis, October 2020. URL: http://dx.doi.org/10.1002/jcla.23637, doi:10.1002/jcla.23637. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcla.23637)

[7. (Kautz2001SHP1) Bryan Kautz, Renu Kakar, Ebenezer David, and Elizabeth A. Eklund. Shp1 protein-tyrosine phosphatase inhibits gp91phoxand p67phox expression by inhibiting interaction of pu.1, irf1, interferon consensus sequence-binding protein, and creb-binding protein with homologous cis elements in the cybb andncf2 genes. Journal of Biological Chemistry, 276(41):37868–37878, October 2001. URL: http://dx.doi.org/10.1074/JBC.M103381200, doi:10.1074/jbc.m103381200. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M103381200)

[8. (Di2009Molecular) Gigliola Di Matteo, Lucia Giordani, Andrea Finocchi, Annamaria Ventura, Maria Chiriaco, Jan Blancato, Cecilia Sinibaldi, Alessandro Plebani, Annarosa Soresina, Claudio Pignata, Rosa Maria Dellepiane, Antonino Trizzino, Fausto Cossu, Roberto Rondelli, Paolo Rossi, Domenico De Mattia, and Baldassarre Martire. Molecular characterization of a large cohort of patients with chronic granulomatous disease and identification of novel cybb mutations: an italian multicenter study. Molecular Immunology, 46(10):1935–1941, June 2009. URL: http://dx.doi.org/10.1016/j.molimm.2009.03.016, doi:10.1016/j.molimm.2009.03.016. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2009.03.016)

[9. (Bustamante2011Germline) Jacinta Bustamante, Andres A Arias, Guillaume Vogt, Capucine Picard, Lizbeth Blancas Galicia, Carolina Prando, Audrey V Grant, Christophe C Marchal, Marjorie Hubeau, Ariane Chapgier, Ludovic de Beaucoudrey, Anne Puel, Jacqueline Feinberg, Ethan Valinetz, Lucile Jannière, Céline Besse, Anne Boland, Jean-Marie Brisseau, Stéphane Blanche, Olivier Lortholary, Claire Fieschi, Jean-François Emile, Stéphanie Boisson-Dupuis, Saleh Al-Muhsen, Bruce Woda, Peter E Newburger, Antonio Condino-Neto, Mary C Dinauer, Laurent Abel, and Jean-Laurent Casanova. Germline cybb mutations that selectively affect macrophages in kindreds with x-linked predisposition to tuberculous mycobacterial disease. Nature Immunology, 12(3):213–221, January 2011. URL: http://dx.doi.org/10.1038/ni.1992, doi:10.1038/ni.1992. This article has 235 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ni.1992)

[10. (Quinn2004Structure) Mark T Quinn and Katherine A Gauss. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. Journal of Leukocyte Biology, 76(4):760–781, July 2004. URL: http://dx.doi.org/10.1189/jlb.0404216, doi:10.1189/jlb.0404216. This article has 359 citations and is from a peer-reviewed journal.](https://doi.org/10.1189/jlb.0404216)